Research and Development

Showing 15 posts of 9604 posts found.

shutterstock_38078521

Real-world data prove efficacy of Eisai and Bial’s epilepsy treatment

September 6, 2017 Research and Development Bial, Eisai, Zebinix, epilepsy, pharma

Bial and Eisai have released real-world data which support the efficacy of Zebinix (eslicarbazepine acetate) in the treatment of partial-onset …
narasimhan_2

Novartis exec designated as new CEO after Jimenez announces retirement

September 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Novartis, a, joe jimenez, phar, pharma, pharmaceuticals

Novartis has announced that its Chief Executive, Joe Jimenez, is set to retire next year. In his place, Vasant Narasimhan …

Takeda’s Ninlaro knocked back by NICE for second time

September 5, 2017 Research and Development, Sales and Marketing Ninlaro, Takeda, biotech, drugs, pharma, pharmaceutical

NICE has revealed that the outcome of its consultation process for Ninlaro (ixazomib), Takeda’s treatment for relapsed or refractory multiple …
novartis_side_building

Novartis celebrates success of Gilenya in paediatric multiple sclerosis

September 5, 2017 Manufacturing and Production, Research and Development MS, Novartis, gilenya, health, multiple sclerosis, pharma, pharmaceuticals

Novartis has announced results of its Phase 3 study investigating the safety and efficacy of Gilenya (fingolimod) , finding that …
asthma

Asthma drugs reduce Parkinson’s risk by 50%, decade-long study finds

September 5, 2017 Manufacturing and Production, Research and Development Parkinson's, Parkinson's disease, asthma, pharma, pharmaceuticals, salbutamol

A study from the Department of Global Public Health and Primary Care at the University of Bergen (UiB) in Norway …
entrance_takeda_i020_v1

Takeda partners up to develop “next generation” CAR T solid tumour therapy

September 4, 2017 Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, Noile-Immune, Takeda, pharma, pharmaceuticals

Takeda is set to partner with Noile-Immune Biotech in the development of a “next generation” chimeric antigen receptor T-cell (CAR …

Sanofi backs out of controversial Zika vaccine project

September 4, 2017 Research and Development, Sales and Marketing Sanofi, US, Vaccine, Zika, biotech, drugs, pharma, pharmaceutical

Sanofi’s development of a Zika vaccine, alongside the US’s Biomedical Advanced Research and Development Authority (BARDA), has hit the headlines …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Trump, drugs, health, life sciences, medicine, pharma, pharmaceutical, top ten

This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its …

R&D tax credits: A novel approach to supply chain funding

September 1, 2017 Manufacturing and Production, Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical, tax credits

Jenny Tragner, director at R&D tax credit consultancy ForrestBrown and member of HMRC’s R&D Consultative Committee, says R&D tax credits …
novartis_hq_day

CAR-T treatment is given ‘historic’ first approval by FDA

August 31, 2017 Research and Development, Sales and Marketing CAR-T, Kymriah, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis has received approval for its CAR-T treatment of paediatric and young adults with a form of acute lymphoblastic leukaemia …
2000px-flag_of_south_korea

J&J offers $134,000 grant to find the best start-up in South Korea

August 31, 2017 Research and Development J&J. pharma, Johnson & Johnson, drugs, life sciences, medicine, pharmaceutical, south korea

Johnson & Johnson is doubling down its efforts to grow its business in East Asia by identifying and recruiting promising …
governance_guenterpeter

EVP of Diabetes decamps from Sanofi to become Almirall CEO

August 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi’s Executive Vice President of Diabetes & Cardiocascular, Peter Guenter, has opted to end his 22-year-long stay at the company …
The Gateway to Local Adoption Series

Latest content